Genexine (XKRX:095700) Other Current Liabilities : ₩3,691 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Genexine Other Current Liabilities?

Genexine's other current liabilities for the quarter that ended in Mar. 2024 was ₩3,691 Mil.

Genexine's quarterly other current liabilities declined from Sep. 2023 (₩9,501 Mil) to Dec. 2023 (₩4,744 Mil) and declined from Dec. 2023 (₩4,744 Mil) to Mar. 2024 (₩3,691 Mil).

Genexine's annual other current liabilities declined from Dec. 2021 (₩25,753 Mil) to Dec. 2022 (₩9,992 Mil) and declined from Dec. 2022 (₩9,992 Mil) to Dec. 2023 (₩4,744 Mil).

Genexine Other Current Liabilities Historical Data

The historical data trend for Genexine's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Other Current Liabilities Chart

Genexine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Genexine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Genexine Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Genexine Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Genexine's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genexine (XKRX:095700) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488

Website

http://www.genexine.com

Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines